Z-1091-2017 Class II Terminated

Recalled by Merge Healthcare, Inc. — Hartland, WI

FDA device recall Z-1091-2017 was initiated by Merge Healthcare, Inc. on Mar 28, 2016 and is designated Class II. Reason for recall: There is a potential connection issue when powering up the Merge Hemo Record Station and the Hemo Monitor does not communicate with the Client PC. The recall status is terminated (terminated Jun 28, 2019). Affected quantity: 242 sites potentially have the affected versions.

Recall details

Product Type
Devices
Report Date
Feb 1, 2017
Initiation Date
Mar 28, 2016
Termination Date
Jun 28, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
242 sites potentially have the affected versions

Product description

Merge Hemo software. Merge Hemo monitors, measures, and records physiologic data from a human patient undergoing a cardiac catheterization procedure

Reason for recall

There is a potential connection issue when powering up the Merge Hemo Record Station and the Hemo Monitor does not communicate with the Client PC.

Distribution pattern

Nationwide Distribution

Code information

Versions 6.10, 6.10.1, 6.10.2, 6.10.3, 7.10, 7.20, 7.20.1, 8.10.0, 8.20, 9.10.0, 9.20, 9.20.2, 9.20.3, 9.30, 9.40, 9.40.1, 9.40.2, and 9.40.3

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1091-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1091-2017. Report a data issue: hello@regdatalab.com.